Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON31371
NL-OMON31371
Not yet recruiting
Not Applicable

Modification of Cardiovascular Risk and Management with MSCT coronary imaging - MSCT to improve cardiovascular management

eids Universitair Medisch Centrum0 sites450 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAtherosclerosiscoronary artery disease10011082

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atherosclerosis
Sponsor
eids Universitair Medisch Centrum
Enrollment
450
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- without symptoms typical for CAD,
  • •\- 45\-70 years of age and
  • •\- at high\-risk for cardiovascular events, defined as having: a \>10% risk on cardiovascular mortality and morbidity according to SCORE adjusted for the Netherlands, or diabetes mellitus.
  • •\- Stable heart rate as a prerequisite for MSCT

Exclusion Criteria

  • •\-Known CAD
  • •\- Ventricular arrhythmia
  • •\- Other serious medical illness
  • •\- Participation in other study
  • •\- Additional specific MSCT criteria
  • •1\. Renal dysfunction (defined as serum creatinine \> 120 mmol/L
  • •2\. Contrast allergy
  • •3\. Irregular heart rhythm
  • •4\. Fast heart rate in combination with contra\-indications against beta\-blocking medication
  • •5\. Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Implementation of Cardiovascular Risk management for patients with Rheumatoïd Arthritis (I-CaRe)cardiovascular disease and atherosclerosis100110821000381610003216
NL-OMON41344Jan van Breemen Instituut3,200
Completed
Not Applicable
The effect of different cardiovascular risk presentation formats on individuals? intentions, understanding and emotional affect.
ISRCTN91319318Cardiff University (UK)800
Recruiting
Phase 1
StopstudyTransgender women using long-term gender-affirming hormone therapyTherapeutic area: Psychiatry and Psychology [F] - Psychological Phenomena [F02]Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
CTIS2023-505143-39-00Amsterdam UMC30
Active, not recruiting
Phase 1
CREATE. Cardiovascular Risk Evaluation and Attenuation of inflammation by early rosuvastatin TrEatment - CREATE
EUCTR2006-001860-22-ISKarl Andersen
Active, not recruiting
Not Applicable
Status of medical management of vascular risk factors before and after stroke in KoreaDiseases of the circulatory system
KCT0000671Seoul National University Hospital54,000